Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - December 29.01.2026 MDEC.LN IE0007FIJUO5 50,002.00 USD 1,376,352.81 27.526 ...
-
Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Growth Strength UCITS ETF 29.01.2026 FTEG.LN IE0009F7UB30 150,002.00 EUR 3,130,551.82 20.870 ...
-
Wadhwani Foundation Deepens State and City Execution in Brazil to Deliver 2.5 Million Jobs and Enable 6 Million Placements by 2030, Globally
SAO PAULO--(BUSINESS WIRE)--Wadhwani Foundation, a global not-for-profit focused on job creation, is strengthening its local execution model in Brazil....
-
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)
MORGES, Switzerland--(BUSINESS WIRE)--Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF - September 29.01.2026 MSEP.LN IE0009DRFET8 150,002.00 USD 4,071,601.79 27.144 ...
-
Greenland Resources Provides Update and Will Present at BMO Conference in Florida
TORONTO--(BUSINESS WIRE)--Greenland Resources Inc. (TSX:MOLY | FSE: M0LY) (“Greenland Resources” or the “Company”) is pleased to announce the Company’s ongoing progress on it Malmbjerg project in Greenland (the “Project”). Highlights The Company will present the Project on February 24, 2026, at 11.15 am EST at the BMO Capital Markets' 35th Global Metals, Mining & Critical Minerals Conference in Hollywood, Florida. The Company has also been invited to participate in round table discussions a...
-
AM Best Affirms Credit Ratings of Ghana Reinsurance PLC
LONDON--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of C++ (Marginal) and the Long-Term Issuer Credit Rating of “b+” (Marginal) of Ghana Reinsurance PLC (Ghana Re) (Ghana). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect Ghana Re’s balance sheet strength, which AM Best assesses as strong, as well as the company’s adequate operating performance, limited business profile and weak enterprise risk management. Ghana Re’s balance sheet strength is...
-
Candela läutet mit der Einführung des Glacē™-Systems eine neue Ära der ästhetischen Innovation auf der IMCAS Paris ein
PARIS--(BUSINESS WIRE)--Candela, ein weltweit führender Anbieter von energiebasierten ästhetischen Technologien, gab heute die europäische Markteinführung des Glacē™-Systems bekannt, einer Plattform für Gesichtsbehandlungen, die ein neues Kapitel für das Unternehmen und die Zukunft der ästhetischen Medizin einläutet. Neben der Einführung des Glacē-Systems wird Candela auf der IMCAS 2026 auch sein Matrix-System für die radiofrequenzbasierte Hauterneuerung und seine legendäre Vbeam®-Pro-Plattform...
-
Candela inaugura una nueva era de innovación estética en IMCAS París con el lanzamiento de Glacē™ System
PARÍS--(BUSINESS WIRE)--Candela, líder internacional en tecnologías estéticas basadas en energía, ha anunciado hoy el lanzamiento en Europa de Glacē™ System, una plataforma de tratamientos faciales que supone un nuevo y ambicioso capítulo para la empresa y el futuro de la medicina estética. Además del lanzamiento de Glacē System, Candela también presentará en IMCAS 2026 su sistema Matrix para la renovación cutánea mediante radiofrecuencia y su emblemática plataforma de tratamiento vascular Vbea...